Kevin Yeaman - Feb 12, 2024 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Role
President and CEO, Director
Signature
/s/ Daniel Rodriguez as Attorney-in-Fact for Kevin Yeaman
Stock symbol
DLB
Transactions as of
Feb 12, 2024
Transactions value $
$0
Form type
4
Date filed
2/14/2024, 04:22 PM
Previous filing
Jan 19, 2024
Next filing
Jun 25, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DLB Employee Stock Option (Right to Buy) Gift $0 -81.9K -50% $0.00 81.9K Feb 12, 2024 Class A Common Stock 81.9K $87.49 Direct F1, F2
transaction DLB Employee Stock Option (Right to Buy) Gift $0 +81.9K $0.00 81.9K Feb 12, 2024 Class A Common Stock 81.9K $87.49 By a trust F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective February 12, 2024, the Reporting Person transferred this option to a revocable trust for no consideration, for estate planning purposes.
F2 This option was granted for a total of 81,884 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2023, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter.
F3 By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009